nodes	percent_of_prediction	percent_of_DWPC	metapath
Ondansetron—SLC47A2—Mitoxantrone—multiple sclerosis	0.352	0.49	CbGbCtD
Ondansetron—SLC47A1—Mitoxantrone—multiple sclerosis	0.146	0.203	CbGbCtD
Ondansetron—CYP2E1—Fingolimod—multiple sclerosis	0.0506	0.0704	CbGbCtD
Ondansetron—CYP2D6—Fingolimod—multiple sclerosis	0.0241	0.0336	CbGbCtD
Ondansetron—CYP2E1—Mitoxantrone—multiple sclerosis	0.0238	0.0331	CbGbCtD
Ondansetron—HTR1B—trigeminal nucleus—multiple sclerosis	0.0232	0.272	CbGeAlD
Ondansetron—HTR3A—area postrema—multiple sclerosis	0.0204	0.239	CbGeAlD
Ondansetron—CYP3A4—Fingolimod—multiple sclerosis	0.0153	0.0213	CbGbCtD
Ondansetron—CYP3A7-CYP3A51P—Dexamethasone—multiple sclerosis	0.0128	0.0178	CbGbCtD
Ondansetron—CYP3A7—Dexamethasone—multiple sclerosis	0.0128	0.0178	CbGbCtD
Ondansetron—CYP2E1—Dexamethasone—multiple sclerosis	0.0123	0.0172	CbGbCtD
Ondansetron—CYP3A4—Methylprednisolone—multiple sclerosis	0.00988	0.0138	CbGbCtD
Ondansetron—CYP3A5—Dexamethasone—multiple sclerosis	0.00959	0.0133	CbGbCtD
Ondansetron—CYP3A4—Triamcinolone—multiple sclerosis	0.00749	0.0104	CbGbCtD
Ondansetron—CYP3A4—Mitoxantrone—multiple sclerosis	0.00721	0.01	CbGbCtD
Ondansetron—CYP2C9—Dexamethasone—multiple sclerosis	0.00643	0.00894	CbGbCtD
Ondansetron—CYP3A4—Betamethasone—multiple sclerosis	0.00643	0.00894	CbGbCtD
Ondansetron—CYP3A4—Prednisolone—multiple sclerosis	0.00634	0.00882	CbGbCtD
Ondansetron—HTR1B—trigeminal nerve—multiple sclerosis	0.00609	0.0716	CbGeAlD
Ondansetron—CYP3A4—Prednisone—multiple sclerosis	0.00599	0.00833	CbGbCtD
Ondansetron—CYP2D6—Dexamethasone—multiple sclerosis	0.00588	0.00818	CbGbCtD
Ondansetron—CYP3A4—Dexamethasone—multiple sclerosis	0.00374	0.0052	CbGbCtD
Ondansetron—HTR3A—nerve—multiple sclerosis	0.00265	0.0311	CbGeAlD
Ondansetron—OPRM1—nerve—multiple sclerosis	0.00243	0.0286	CbGeAlD
Ondansetron—HTR4—brain—multiple sclerosis	0.00169	0.0198	CbGeAlD
Ondansetron—SLC47A2—nervous system—multiple sclerosis	0.00167	0.0197	CbGeAlD
Ondansetron—SLC47A2—central nervous system—multiple sclerosis	0.00161	0.0189	CbGeAlD
Ondansetron—SLC47A2—brain—multiple sclerosis	0.00128	0.015	CbGeAlD
Ondansetron—HTR3A—brainstem—multiple sclerosis	0.00114	0.0134	CbGeAlD
Ondansetron—SLC47A1—brainstem—multiple sclerosis	0.00112	0.0131	CbGeAlD
Ondansetron—OPRM1—brainstem—multiple sclerosis	0.00104	0.0123	CbGeAlD
Ondansetron—HTR1B—brainstem—multiple sclerosis	0.000954	0.0112	CbGeAlD
Ondansetron—SLC47A1—medulla oblongata—multiple sclerosis	0.000779	0.00916	CbGeAlD
Ondansetron—HTR1A—brainstem—multiple sclerosis	0.00077	0.00905	CbGeAlD
Ondansetron—SLC47A1—spinal cord—multiple sclerosis	0.000695	0.00817	CbGeAlD
Ondansetron—OPRM1—midbrain—multiple sclerosis	0.000665	0.00781	CbGeAlD
Ondansetron—OPRM1—spinal cord—multiple sclerosis	0.000649	0.00762	CbGeAlD
Ondansetron—HTR1B—midbrain—multiple sclerosis	0.000608	0.00715	CbGeAlD
Ondansetron—HTR3A—nervous system—multiple sclerosis	0.000596	0.00701	CbGeAlD
Ondansetron—HTR1B—spinal cord—multiple sclerosis	0.000593	0.00697	CbGeAlD
Ondansetron—SLC47A1—nervous system—multiple sclerosis	0.000586	0.00688	CbGeAlD
Ondansetron—HTR3A—central nervous system—multiple sclerosis	0.000574	0.00674	CbGeAlD
Ondansetron—SLC47A1—central nervous system—multiple sclerosis	0.000564	0.00663	CbGeAlD
Ondansetron—SLC47A1—cerebellum—multiple sclerosis	0.000551	0.00648	CbGeAlD
Ondansetron—OPRM1—nervous system—multiple sclerosis	0.000546	0.00642	CbGeAlD
Ondansetron—OPRM1—central nervous system—multiple sclerosis	0.000526	0.00618	CbGeAlD
Ondansetron—HTR1B—nervous system—multiple sclerosis	0.0005	0.00588	CbGeAlD
Ondansetron—HTR1A—midbrain—multiple sclerosis	0.000491	0.00577	CbGeAlD
Ondansetron—HTR1B—central nervous system—multiple sclerosis	0.000481	0.00566	CbGeAlD
Ondansetron—HTR1A—spinal cord—multiple sclerosis	0.000479	0.00563	CbGeAlD
Ondansetron—KCNH2—medulla oblongata—multiple sclerosis	0.000478	0.00562	CbGeAlD
Ondansetron—HTR3A—brain—multiple sclerosis	0.000456	0.00535	CbGeAlD
Ondansetron—SLC47A1—brain—multiple sclerosis	0.000448	0.00526	CbGeAlD
Ondansetron—KCNH2—midbrain—multiple sclerosis	0.000437	0.00514	CbGeAlD
Ondansetron—KCNH2—spinal cord—multiple sclerosis	0.000426	0.00501	CbGeAlD
Ondansetron—CYP2D6—brainstem—multiple sclerosis	0.000418	0.00491	CbGeAlD
Ondansetron—OPRM1—brain—multiple sclerosis	0.000418	0.00491	CbGeAlD
Ondansetron—HTR1A—nervous system—multiple sclerosis	0.000404	0.00474	CbGeAlD
Ondansetron—HTR1A—central nervous system—multiple sclerosis	0.000389	0.00457	CbGeAlD
Ondansetron—HTR1B—brain—multiple sclerosis	0.000382	0.00449	CbGeAlD
Ondansetron—HTR1A—cerebellum—multiple sclerosis	0.00038	0.00446	CbGeAlD
Ondansetron—CYP2E1—medulla oblongata—multiple sclerosis	0.000368	0.00433	CbGeAlD
Ondansetron—KCNH2—nervous system—multiple sclerosis	0.000359	0.00422	CbGeAlD
Ondansetron—KCNH2—central nervous system—multiple sclerosis	0.000346	0.00407	CbGeAlD
Ondansetron—KCNH2—cerebellum—multiple sclerosis	0.000338	0.00397	CbGeAlD
Ondansetron—CYP2E1—spinal cord—multiple sclerosis	0.000328	0.00386	CbGeAlD
Ondansetron—HTR1A—brain—multiple sclerosis	0.000308	0.00363	CbGeAlD
Ondansetron—CYP2E1—nervous system—multiple sclerosis	0.000277	0.00325	CbGeAlD
Ondansetron—KCNH2—brain—multiple sclerosis	0.000275	0.00323	CbGeAlD
Ondansetron—CYP2E1—central nervous system—multiple sclerosis	0.000266	0.00313	CbGeAlD
Ondansetron—CYP2E1—cerebellum—multiple sclerosis	0.00026	0.00306	CbGeAlD
Ondansetron—CYP3A4—nervous system—multiple sclerosis	0.000223	0.00262	CbGeAlD
Ondansetron—CYP2D6—nervous system—multiple sclerosis	0.000219	0.00257	CbGeAlD
Ondansetron—CYP3A4—central nervous system—multiple sclerosis	0.000214	0.00252	CbGeAlD
Ondansetron—CYP2E1—brain—multiple sclerosis	0.000212	0.00249	CbGeAlD
Ondansetron—CYP2D6—central nervous system—multiple sclerosis	0.000211	0.00248	CbGeAlD
Ondansetron—CYP2D6—cerebellum—multiple sclerosis	0.000206	0.00242	CbGeAlD
Ondansetron—Somnolence—Mitoxantrone—multiple sclerosis	0.000192	0.00155	CcSEcCtD
Ondansetron—Loss of consciousness—Prednisolone—multiple sclerosis	0.000191	0.00154	CcSEcCtD
Ondansetron—Asthma—Methotrexate—multiple sclerosis	0.000189	0.00153	CcSEcCtD
Ondansetron—Angiopathy—Dexamethasone—multiple sclerosis	0.000189	0.00152	CcSEcCtD
Ondansetron—Angiopathy—Betamethasone—multiple sclerosis	0.000189	0.00152	CcSEcCtD
Ondansetron—Convulsion—Prednisolone—multiple sclerosis	0.000188	0.00152	CcSEcCtD
Ondansetron—Fatigue—Mitoxantrone—multiple sclerosis	0.000186	0.0015	CcSEcCtD
Ondansetron—Arrhythmia—Dexamethasone—multiple sclerosis	0.000186	0.0015	CcSEcCtD
Ondansetron—Arrhythmia—Betamethasone—multiple sclerosis	0.000186	0.0015	CcSEcCtD
Ondansetron—Ill-defined disorder—Triamcinolone—multiple sclerosis	0.000185	0.0015	CcSEcCtD
Ondansetron—Ill-defined disorder—Methylprednisolone—multiple sclerosis	0.000185	0.00149	CcSEcCtD
Ondansetron—Constipation—Mitoxantrone—multiple sclerosis	0.000184	0.00149	CcSEcCtD
Ondansetron—Pain—Mitoxantrone—multiple sclerosis	0.000184	0.00149	CcSEcCtD
Ondansetron—Bradycardia—Prednisone—multiple sclerosis	0.000184	0.00149	CcSEcCtD
Ondansetron—Diarrhoea—Azathioprine—multiple sclerosis	0.000183	0.00148	CcSEcCtD
Ondansetron—Discomfort—Prednisolone—multiple sclerosis	0.000182	0.00147	CcSEcCtD
Ondansetron—Angioedema—Triamcinolone—multiple sclerosis	0.000182	0.00147	CcSEcCtD
Ondansetron—Haemoglobin—Prednisone—multiple sclerosis	0.000182	0.00147	CcSEcCtD
Ondansetron—Angioedema—Methylprednisolone—multiple sclerosis	0.000182	0.00147	CcSEcCtD
Ondansetron—Haemorrhage—Prednisone—multiple sclerosis	0.000181	0.00146	CcSEcCtD
Ondansetron—Erythema—Betamethasone—multiple sclerosis	0.000181	0.00146	CcSEcCtD
Ondansetron—Erythema—Dexamethasone—multiple sclerosis	0.000181	0.00146	CcSEcCtD
Ondansetron—Malaise—Triamcinolone—multiple sclerosis	0.00018	0.00145	CcSEcCtD
Ondansetron—Malaise—Methylprednisolone—multiple sclerosis	0.000179	0.00145	CcSEcCtD
Ondansetron—Syncope—Triamcinolone—multiple sclerosis	0.000179	0.00145	CcSEcCtD
Ondansetron—Syncope—Methylprednisolone—multiple sclerosis	0.000178	0.00144	CcSEcCtD
Ondansetron—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000178	0.00144	CcSEcCtD
Ondansetron—Anaphylactic shock—Prednisolone—multiple sclerosis	0.000177	0.00143	CcSEcCtD
Ondansetron—Dysuria—Methotrexate—multiple sclerosis	0.000177	0.00143	CcSEcCtD
Ondansetron—Dizziness—Azathioprine—multiple sclerosis	0.000176	0.00143	CcSEcCtD
Ondansetron—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.000176	0.00143	CcSEcCtD
Ondansetron—Loss of consciousness—Triamcinolone—multiple sclerosis	0.000175	0.00142	CcSEcCtD
Ondansetron—Loss of consciousness—Methylprednisolone—multiple sclerosis	0.000175	0.00141	CcSEcCtD
Ondansetron—Shock—Prednisolone—multiple sclerosis	0.000174	0.00141	CcSEcCtD
Ondansetron—Cough—Triamcinolone—multiple sclerosis	0.000174	0.00141	CcSEcCtD
Ondansetron—Convulsion—Triamcinolone—multiple sclerosis	0.000173	0.0014	CcSEcCtD
Ondansetron—Tachycardia—Prednisolone—multiple sclerosis	0.000173	0.0014	CcSEcCtD
Ondansetron—Convulsion—Methylprednisolone—multiple sclerosis	0.000172	0.00139	CcSEcCtD
Ondansetron—Urticaria—Mitoxantrone—multiple sclerosis	0.000171	0.00139	CcSEcCtD
Ondansetron—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000171	0.00138	CcSEcCtD
Ondansetron—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000171	0.00138	CcSEcCtD
Ondansetron—Vomiting—Azathioprine—multiple sclerosis	0.00017	0.00137	CcSEcCtD
Ondansetron—Eye disorder—Prednisone—multiple sclerosis	0.000169	0.00137	CcSEcCtD
Ondansetron—Anxiety—Methylprednisolone—multiple sclerosis	0.000169	0.00136	CcSEcCtD
Ondansetron—Drowsiness—Methotrexate—multiple sclerosis	0.000169	0.00136	CcSEcCtD
Ondansetron—Rash—Azathioprine—multiple sclerosis	0.000168	0.00136	CcSEcCtD
Ondansetron—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.000168	0.00136	CcSEcCtD
Ondansetron—Dermatitis—Azathioprine—multiple sclerosis	0.000168	0.00136	CcSEcCtD
Ondansetron—Flushing—Prednisone—multiple sclerosis	0.000168	0.00136	CcSEcCtD
Ondansetron—Ill-defined disorder—Betamethasone—multiple sclerosis	0.000168	0.00136	CcSEcCtD
Ondansetron—Ill-defined disorder—Dexamethasone—multiple sclerosis	0.000168	0.00136	CcSEcCtD
Ondansetron—Discomfort—Triamcinolone—multiple sclerosis	0.000168	0.00136	CcSEcCtD
Ondansetron—CYP2D6—brain—multiple sclerosis	0.000167	0.00197	CbGeAlD
Ondansetron—Discomfort—Methylprednisolone—multiple sclerosis	0.000167	0.00135	CcSEcCtD
Ondansetron—Headache—Azathioprine—multiple sclerosis	0.000167	0.00135	CcSEcCtD
Ondansetron—Stevens-Johnson syndrome—Methotrexate—multiple sclerosis	0.000167	0.00135	CcSEcCtD
Ondansetron—Dry mouth—Triamcinolone—multiple sclerosis	0.000166	0.00134	CcSEcCtD
Ondansetron—Angioedema—Betamethasone—multiple sclerosis	0.000165	0.00134	CcSEcCtD
Ondansetron—Angioedema—Dexamethasone—multiple sclerosis	0.000165	0.00134	CcSEcCtD
Ondansetron—Angiopathy—Prednisone—multiple sclerosis	0.000164	0.00133	CcSEcCtD
Ondansetron—Immune system disorder—Prednisone—multiple sclerosis	0.000164	0.00132	CcSEcCtD
Ondansetron—Malaise—Betamethasone—multiple sclerosis	0.000163	0.00132	CcSEcCtD
Ondansetron—Malaise—Dexamethasone—multiple sclerosis	0.000163	0.00132	CcSEcCtD
Ondansetron—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.000163	0.00132	CcSEcCtD
Ondansetron—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000162	0.00131	CcSEcCtD
Ondansetron—Syncope—Betamethasone—multiple sclerosis	0.000162	0.00131	CcSEcCtD
Ondansetron—Syncope—Dexamethasone—multiple sclerosis	0.000162	0.00131	CcSEcCtD
Ondansetron—Arrhythmia—Prednisone—multiple sclerosis	0.000162	0.00131	CcSEcCtD
Ondansetron—Shock—Triamcinolone—multiple sclerosis	0.00016	0.00129	CcSEcCtD
Ondansetron—Shock—Methylprednisolone—multiple sclerosis	0.00016	0.00129	CcSEcCtD
Ondansetron—Hepatobiliary disease—Methotrexate—multiple sclerosis	0.000159	0.00129	CcSEcCtD
Ondansetron—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000159	0.00129	CcSEcCtD
Ondansetron—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000159	0.00129	CcSEcCtD
Ondansetron—Loss of consciousness—Betamethasone—multiple sclerosis	0.000159	0.00129	CcSEcCtD
Ondansetron—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000159	0.00128	CcSEcCtD
Ondansetron—Paraesthesia—Prednisolone—multiple sclerosis	0.000159	0.00128	CcSEcCtD
Ondansetron—Tachycardia—Triamcinolone—multiple sclerosis	0.000159	0.00128	CcSEcCtD
Ondansetron—Tachycardia—Methylprednisolone—multiple sclerosis	0.000158	0.00128	CcSEcCtD
Ondansetron—Skin disorder—Methylprednisolone—multiple sclerosis	0.000158	0.00128	CcSEcCtD
Ondansetron—Erythema—Prednisone—multiple sclerosis	0.000158	0.00127	CcSEcCtD
Ondansetron—Convulsion—Dexamethasone—multiple sclerosis	0.000157	0.00127	CcSEcCtD
Ondansetron—Convulsion—Betamethasone—multiple sclerosis	0.000157	0.00127	CcSEcCtD
Ondansetron—Asthenia—Mitoxantrone—multiple sclerosis	0.000155	0.00125	CcSEcCtD
Ondansetron—Anxiety—Dexamethasone—multiple sclerosis	0.000154	0.00124	CcSEcCtD
Ondansetron—Anxiety—Betamethasone—multiple sclerosis	0.000154	0.00124	CcSEcCtD
Ondansetron—Discomfort—Betamethasone—multiple sclerosis	0.000152	0.00123	CcSEcCtD
Ondansetron—Discomfort—Dexamethasone—multiple sclerosis	0.000152	0.00123	CcSEcCtD
Ondansetron—Haemoglobin—Methotrexate—multiple sclerosis	0.000152	0.00123	CcSEcCtD
Ondansetron—Hypotension—Methylprednisolone—multiple sclerosis	0.000152	0.00123	CcSEcCtD
Ondansetron—Pain—Prednisolone—multiple sclerosis	0.000151	0.00122	CcSEcCtD
Ondansetron—Haemorrhage—Methotrexate—multiple sclerosis	0.000151	0.00122	CcSEcCtD
Ondansetron—Vision blurred—Prednisone—multiple sclerosis	0.000149	0.0012	CcSEcCtD
Ondansetron—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000148	0.00119	CcSEcCtD
Ondansetron—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000148	0.00119	CcSEcCtD
Ondansetron—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000148	0.00119	CcSEcCtD
Ondansetron—Ill-defined disorder—Prednisone—multiple sclerosis	0.000146	0.00118	CcSEcCtD
Ondansetron—Paraesthesia—Triamcinolone—multiple sclerosis	0.000146	0.00118	CcSEcCtD
Ondansetron—Feeling abnormal—Prednisolone—multiple sclerosis	0.000146	0.00118	CcSEcCtD
Ondansetron—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000146	0.00118	CcSEcCtD
Ondansetron—Visual impairment—Methotrexate—multiple sclerosis	0.000146	0.00118	CcSEcCtD
Ondansetron—Shock—Dexamethasone—multiple sclerosis	0.000145	0.00117	CcSEcCtD
Ondansetron—Shock—Betamethasone—multiple sclerosis	0.000145	0.00117	CcSEcCtD
Ondansetron—Dyspnoea—Triamcinolone—multiple sclerosis	0.000145	0.00117	CcSEcCtD
Ondansetron—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000145	0.00117	CcSEcCtD
Ondansetron—Nervous system disorder—Betamethasone—multiple sclerosis	0.000145	0.00117	CcSEcCtD
Ondansetron—Agitation—Prednisone—multiple sclerosis	0.000145	0.00117	CcSEcCtD
Ondansetron—Tachycardia—Dexamethasone—multiple sclerosis	0.000144	0.00117	CcSEcCtD
Ondansetron—Tachycardia—Betamethasone—multiple sclerosis	0.000144	0.00117	CcSEcCtD
Ondansetron—Angioedema—Prednisone—multiple sclerosis	0.000144	0.00116	CcSEcCtD
Ondansetron—Erythema multiforme—Methotrexate—multiple sclerosis	0.000143	0.00116	CcSEcCtD
Ondansetron—Malaise—Prednisone—multiple sclerosis	0.000142	0.00115	CcSEcCtD
Ondansetron—Eye disorder—Methotrexate—multiple sclerosis	0.000141	0.00114	CcSEcCtD
Ondansetron—Syncope—Prednisone—multiple sclerosis	0.000141	0.00114	CcSEcCtD
Ondansetron—Urticaria—Prednisolone—multiple sclerosis	0.000141	0.00114	CcSEcCtD
Ondansetron—Cardiac disorder—Methotrexate—multiple sclerosis	0.00014	0.00114	CcSEcCtD
Ondansetron—Fatigue—Triamcinolone—multiple sclerosis	0.00014	0.00113	CcSEcCtD
Ondansetron—Fatigue—Methylprednisolone—multiple sclerosis	0.00014	0.00113	CcSEcCtD
Ondansetron—Pain—Triamcinolone—multiple sclerosis	0.000139	0.00113	CcSEcCtD
Ondansetron—Loss of consciousness—Prednisone—multiple sclerosis	0.000138	0.00112	CcSEcCtD
Ondansetron—Hypotension—Betamethasone—multiple sclerosis	0.000138	0.00112	CcSEcCtD
Ondansetron—Hypotension—Dexamethasone—multiple sclerosis	0.000138	0.00112	CcSEcCtD
Ondansetron—Angiopathy—Methotrexate—multiple sclerosis	0.000137	0.00111	CcSEcCtD
Ondansetron—Vomiting—Mitoxantrone—multiple sclerosis	0.000137	0.00111	CcSEcCtD
Ondansetron—Immune system disorder—Methotrexate—multiple sclerosis	0.000137	0.0011	CcSEcCtD
Ondansetron—Convulsion—Prednisone—multiple sclerosis	0.000137	0.0011	CcSEcCtD
Ondansetron—Mediastinal disorder—Methotrexate—multiple sclerosis	0.000136	0.0011	CcSEcCtD
Ondansetron—Rash—Mitoxantrone—multiple sclerosis	0.000136	0.0011	CcSEcCtD
Ondansetron—Dermatitis—Mitoxantrone—multiple sclerosis	0.000136	0.0011	CcSEcCtD
Ondansetron—Chills—Methotrexate—multiple sclerosis	0.000136	0.0011	CcSEcCtD
Ondansetron—Headache—Mitoxantrone—multiple sclerosis	0.000135	0.00109	CcSEcCtD
Ondansetron—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000134	0.00108	CcSEcCtD
Ondansetron—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000134	0.00108	CcSEcCtD
Ondansetron—Anxiety—Prednisone—multiple sclerosis	0.000134	0.00108	CcSEcCtD
Ondansetron—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000133	0.00108	CcSEcCtD
Ondansetron—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000133	0.00107	CcSEcCtD
Ondansetron—Paraesthesia—Dexamethasone—multiple sclerosis	0.000133	0.00107	CcSEcCtD
Ondansetron—Paraesthesia—Betamethasone—multiple sclerosis	0.000133	0.00107	CcSEcCtD
Ondansetron—Discomfort—Prednisone—multiple sclerosis	0.000133	0.00107	CcSEcCtD
Ondansetron—Erythema—Methotrexate—multiple sclerosis	0.000132	0.00106	CcSEcCtD
Ondansetron—Hypersensitivity—Prednisolone—multiple sclerosis	0.00013	0.00105	CcSEcCtD
Ondansetron—Urticaria—Triamcinolone—multiple sclerosis	0.000129	0.00105	CcSEcCtD
Ondansetron—Urticaria—Methylprednisolone—multiple sclerosis	0.000129	0.00104	CcSEcCtD
Ondansetron—Body temperature increased—Triamcinolone—multiple sclerosis	0.000129	0.00104	CcSEcCtD
Ondansetron—Anaphylactic shock—Prednisone—multiple sclerosis	0.000129	0.00104	CcSEcCtD
Ondansetron—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000128	0.00104	CcSEcCtD
Ondansetron—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000127	0.00103	CcSEcCtD
Ondansetron—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000127	0.00103	CcSEcCtD
Ondansetron—Fatigue—Dexamethasone—multiple sclerosis	0.000127	0.00103	CcSEcCtD
Ondansetron—Fatigue—Betamethasone—multiple sclerosis	0.000127	0.00103	CcSEcCtD
Ondansetron—Shock—Prednisone—multiple sclerosis	0.000127	0.00102	CcSEcCtD
Ondansetron—Pain—Betamethasone—multiple sclerosis	0.000126	0.00102	CcSEcCtD
Ondansetron—Pain—Dexamethasone—multiple sclerosis	0.000126	0.00102	CcSEcCtD
Ondansetron—Nervous system disorder—Prednisone—multiple sclerosis	0.000126	0.00102	CcSEcCtD
Ondansetron—Tachycardia—Prednisone—multiple sclerosis	0.000126	0.00101	CcSEcCtD
Ondansetron—Skin disorder—Prednisone—multiple sclerosis	0.000125	0.00101	CcSEcCtD
Ondansetron—Vision blurred—Methotrexate—multiple sclerosis	0.000124	0.001	CcSEcCtD
Ondansetron—Ill-defined disorder—Methotrexate—multiple sclerosis	0.000122	0.000988	CcSEcCtD
Ondansetron—Feeling abnormal—Betamethasone—multiple sclerosis	0.000122	0.000984	CcSEcCtD
Ondansetron—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000122	0.000984	CcSEcCtD
Ondansetron—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000121	0.000976	CcSEcCtD
Ondansetron—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000121	0.000976	CcSEcCtD
Ondansetron—Hypersensitivity—Triamcinolone—multiple sclerosis	0.00012	0.000969	CcSEcCtD
Ondansetron—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.00012	0.000967	CcSEcCtD
Ondansetron—Malaise—Methotrexate—multiple sclerosis	0.000119	0.00096	CcSEcCtD
Ondansetron—Urticaria—Dexamethasone—multiple sclerosis	0.000117	0.000948	CcSEcCtD
Ondansetron—Urticaria—Betamethasone—multiple sclerosis	0.000117	0.000948	CcSEcCtD
Ondansetron—Dizziness—Prednisolone—multiple sclerosis	0.000117	0.000946	CcSEcCtD
Ondansetron—Asthenia—Triamcinolone—multiple sclerosis	0.000117	0.000944	CcSEcCtD
Ondansetron—Body temperature increased—Dexamethasone—multiple sclerosis	0.000117	0.000944	CcSEcCtD
Ondansetron—Body temperature increased—Betamethasone—multiple sclerosis	0.000117	0.000944	CcSEcCtD
Ondansetron—Abdominal pain—Betamethasone—multiple sclerosis	0.000117	0.000944	CcSEcCtD
Ondansetron—Abdominal pain—Dexamethasone—multiple sclerosis	0.000117	0.000944	CcSEcCtD
Ondansetron—Asthenia—Methylprednisolone—multiple sclerosis	0.000117	0.000942	CcSEcCtD
Ondansetron—Paraesthesia—Prednisone—multiple sclerosis	0.000115	0.000934	CcSEcCtD
Ondansetron—Pruritus—Triamcinolone—multiple sclerosis	0.000115	0.000931	CcSEcCtD
Ondansetron—Cough—Methotrexate—multiple sclerosis	0.000115	0.000929	CcSEcCtD
Ondansetron—Pruritus—Methylprednisolone—multiple sclerosis	0.000115	0.000929	CcSEcCtD
Ondansetron—Convulsion—Methotrexate—multiple sclerosis	0.000114	0.000922	CcSEcCtD
Ondansetron—Chest pain—Methotrexate—multiple sclerosis	0.000112	0.000906	CcSEcCtD
Ondansetron—Rash—Prednisolone—multiple sclerosis	0.000112	0.000902	CcSEcCtD
Ondansetron—Dermatitis—Prednisolone—multiple sclerosis	0.000111	0.000901	CcSEcCtD
Ondansetron—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000111	0.0009	CcSEcCtD
Ondansetron—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000111	0.000898	CcSEcCtD
Ondansetron—Fatigue—Prednisone—multiple sclerosis	0.000111	0.000896	CcSEcCtD
Ondansetron—Headache—Prednisolone—multiple sclerosis	0.000111	0.000896	CcSEcCtD
Ondansetron—Discomfort—Methotrexate—multiple sclerosis	0.000111	0.000896	CcSEcCtD
Ondansetron—Constipation—Prednisone—multiple sclerosis	0.00011	0.000889	CcSEcCtD
Ondansetron—Dizziness—Triamcinolone—multiple sclerosis	0.000108	0.00087	CcSEcCtD
Ondansetron—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000107	0.000869	CcSEcCtD
Ondansetron—Dizziness—Methylprednisolone—multiple sclerosis	0.000107	0.000868	CcSEcCtD
Ondansetron—Feeling abnormal—Prednisone—multiple sclerosis	0.000106	0.000857	CcSEcCtD
Ondansetron—Asthenia—Dexamethasone—multiple sclerosis	0.000106	0.000857	CcSEcCtD
Ondansetron—Asthenia—Betamethasone—multiple sclerosis	0.000106	0.000857	CcSEcCtD
Ondansetron—Nervous system disorder—Methotrexate—multiple sclerosis	0.000105	0.000852	CcSEcCtD
Ondansetron—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000105	0.00085	CcSEcCtD
Ondansetron—Pruritus—Betamethasone—multiple sclerosis	0.000104	0.000845	CcSEcCtD
Ondansetron—Pruritus—Dexamethasone—multiple sclerosis	0.000104	0.000845	CcSEcCtD
Ondansetron—Skin disorder—Methotrexate—multiple sclerosis	0.000104	0.000844	CcSEcCtD
Ondansetron—Vomiting—Triamcinolone—multiple sclerosis	0.000103	0.000837	CcSEcCtD
Ondansetron—Vomiting—Methylprednisolone—multiple sclerosis	0.000103	0.000835	CcSEcCtD
Ondansetron—Rash—Triamcinolone—multiple sclerosis	0.000103	0.00083	CcSEcCtD
Ondansetron—Dermatitis—Triamcinolone—multiple sclerosis	0.000103	0.000829	CcSEcCtD
Ondansetron—Rash—Methylprednisolone—multiple sclerosis	0.000102	0.000828	CcSEcCtD
Ondansetron—Dermatitis—Methylprednisolone—multiple sclerosis	0.000102	0.000827	CcSEcCtD
Ondansetron—Urticaria—Prednisone—multiple sclerosis	0.000102	0.000826	CcSEcCtD
Ondansetron—Headache—Triamcinolone—multiple sclerosis	0.000102	0.000824	CcSEcCtD
Ondansetron—Headache—Methylprednisolone—multiple sclerosis	0.000102	0.000822	CcSEcCtD
Ondansetron—Abdominal pain—Prednisone—multiple sclerosis	0.000102	0.000822	CcSEcCtD
Ondansetron—Body temperature increased—Prednisone—multiple sclerosis	0.000102	0.000822	CcSEcCtD
Ondansetron—Diarrhoea—Betamethasone—multiple sclerosis	0.000101	0.000817	CcSEcCtD
Ondansetron—Diarrhoea—Dexamethasone—multiple sclerosis	0.000101	0.000817	CcSEcCtD
Ondansetron—Hypotension—Methotrexate—multiple sclerosis	0.0001	0.000812	CcSEcCtD
Ondansetron—Dizziness—Dexamethasone—multiple sclerosis	9.77e-05	0.000789	CcSEcCtD
Ondansetron—Dizziness—Betamethasone—multiple sclerosis	9.77e-05	0.000789	CcSEcCtD
Ondansetron—Paraesthesia—Methotrexate—multiple sclerosis	9.65e-05	0.00078	CcSEcCtD
Ondansetron—Dyspnoea—Methotrexate—multiple sclerosis	9.58e-05	0.000775	CcSEcCtD
Ondansetron—Somnolence—Methotrexate—multiple sclerosis	9.55e-05	0.000772	CcSEcCtD
Ondansetron—Hypersensitivity—Prednisone—multiple sclerosis	9.48e-05	0.000766	CcSEcCtD
Ondansetron—Vomiting—Dexamethasone—multiple sclerosis	9.39e-05	0.000759	CcSEcCtD
Ondansetron—Vomiting—Betamethasone—multiple sclerosis	9.39e-05	0.000759	CcSEcCtD
Ondansetron—Rash—Betamethasone—multiple sclerosis	9.31e-05	0.000753	CcSEcCtD
Ondansetron—Rash—Dexamethasone—multiple sclerosis	9.31e-05	0.000753	CcSEcCtD
Ondansetron—Dermatitis—Betamethasone—multiple sclerosis	9.3e-05	0.000752	CcSEcCtD
Ondansetron—Dermatitis—Dexamethasone—multiple sclerosis	9.3e-05	0.000752	CcSEcCtD
Ondansetron—Gastrointestinal disorder—Methotrexate—multiple sclerosis	9.28e-05	0.00075	CcSEcCtD
Ondansetron—Fatigue—Methotrexate—multiple sclerosis	9.27e-05	0.000749	CcSEcCtD
Ondansetron—Headache—Betamethasone—multiple sclerosis	9.25e-05	0.000748	CcSEcCtD
Ondansetron—Headache—Dexamethasone—multiple sclerosis	9.25e-05	0.000748	CcSEcCtD
Ondansetron—Asthenia—Prednisone—multiple sclerosis	9.23e-05	0.000746	CcSEcCtD
Ondansetron—Pain—Methotrexate—multiple sclerosis	9.19e-05	0.000743	CcSEcCtD
Ondansetron—Pruritus—Prednisone—multiple sclerosis	9.1e-05	0.000736	CcSEcCtD
Ondansetron—Feeling abnormal—Methotrexate—multiple sclerosis	8.86e-05	0.000716	CcSEcCtD
Ondansetron—Diarrhoea—Prednisone—multiple sclerosis	8.8e-05	0.000711	CcSEcCtD
Ondansetron—Gastrointestinal pain—Methotrexate—multiple sclerosis	8.79e-05	0.000711	CcSEcCtD
Ondansetron—Urticaria—Methotrexate—multiple sclerosis	8.54e-05	0.00069	CcSEcCtD
Ondansetron—Dizziness—Prednisone—multiple sclerosis	8.5e-05	0.000688	CcSEcCtD
Ondansetron—Body temperature increased—Methotrexate—multiple sclerosis	8.5e-05	0.000687	CcSEcCtD
Ondansetron—Abdominal pain—Methotrexate—multiple sclerosis	8.5e-05	0.000687	CcSEcCtD
Ondansetron—Vomiting—Prednisone—multiple sclerosis	8.18e-05	0.000661	CcSEcCtD
Ondansetron—Rash—Prednisone—multiple sclerosis	8.11e-05	0.000656	CcSEcCtD
Ondansetron—Dermatitis—Prednisone—multiple sclerosis	8.1e-05	0.000655	CcSEcCtD
Ondansetron—Headache—Prednisone—multiple sclerosis	8.06e-05	0.000651	CcSEcCtD
Ondansetron—Hypersensitivity—Methotrexate—multiple sclerosis	7.92e-05	0.00064	CcSEcCtD
Ondansetron—Asthenia—Methotrexate—multiple sclerosis	7.71e-05	0.000623	CcSEcCtD
Ondansetron—Pruritus—Methotrexate—multiple sclerosis	7.6e-05	0.000615	CcSEcCtD
Ondansetron—Diarrhoea—Methotrexate—multiple sclerosis	7.35e-05	0.000595	CcSEcCtD
Ondansetron—Dizziness—Methotrexate—multiple sclerosis	7.11e-05	0.000575	CcSEcCtD
Ondansetron—Vomiting—Methotrexate—multiple sclerosis	6.83e-05	0.000552	CcSEcCtD
Ondansetron—Rash—Methotrexate—multiple sclerosis	6.78e-05	0.000548	CcSEcCtD
Ondansetron—Dermatitis—Methotrexate—multiple sclerosis	6.77e-05	0.000547	CcSEcCtD
Ondansetron—Headache—Methotrexate—multiple sclerosis	6.73e-05	0.000544	CcSEcCtD
Ondansetron—HTR4—GPCR downstream signaling—IL2—multiple sclerosis	2.97e-05	0.000409	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—CCL3—multiple sclerosis	2.95e-05	0.000407	CbGpPWpGaD
Ondansetron—OPRM1—GPCR downstream signaling—CCR2—multiple sclerosis	2.94e-05	0.000405	CbGpPWpGaD
Ondansetron—KCNH2—Neuronal System—MAPK1—multiple sclerosis	2.93e-05	0.000405	CbGpPWpGaD
Ondansetron—HTR1A—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	2.91e-05	0.000401	CbGpPWpGaD
Ondansetron—HTR1B—GPCR ligand binding—CCL2—multiple sclerosis	2.9e-05	0.0004	CbGpPWpGaD
Ondansetron—HTR1A—GPCR ligand binding—CCR5—multiple sclerosis	2.89e-05	0.000399	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—S1PR1—multiple sclerosis	2.86e-05	0.000395	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—PTGER4—multiple sclerosis	2.84e-05	0.000392	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—SPP1—multiple sclerosis	2.83e-05	0.000391	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—RGS1—multiple sclerosis	2.82e-05	0.000389	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—CNR1—multiple sclerosis	2.79e-05	0.000385	CbGpPWpGaD
Ondansetron—HTR1A—SIDS Susceptibility Pathways—TNF—multiple sclerosis	2.79e-05	0.000385	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—GPC5—multiple sclerosis	2.79e-05	0.000384	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—CCR1—multiple sclerosis	2.77e-05	0.000382	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—CXCL13—multiple sclerosis	2.77e-05	0.000382	CbGpPWpGaD
Ondansetron—HTR1B—GPCR downstream signaling—CXCL10—multiple sclerosis	2.77e-05	0.000382	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—CCR5—multiple sclerosis	2.76e-05	0.00038	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—RRM1—multiple sclerosis	2.75e-05	0.000379	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—CXCR3—multiple sclerosis	2.74e-05	0.000378	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—IL2RA—multiple sclerosis	2.72e-05	0.000375	CbGpPWpGaD
Ondansetron—OPRM1—GPCR downstream signaling—CNR1—multiple sclerosis	2.71e-05	0.000374	CbGpPWpGaD
Ondansetron—HTR1A—GPCR downstream signaling—PTGER4—multiple sclerosis	2.7e-05	0.000372	CbGpPWpGaD
Ondansetron—HTR4—Signaling by GPCR—IL2—multiple sclerosis	2.7e-05	0.000372	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—GPR65—multiple sclerosis	2.68e-05	0.000369	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—CCR2—multiple sclerosis	2.67e-05	0.000368	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—SRM—multiple sclerosis	2.65e-05	0.000365	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—CYP27B1—multiple sclerosis	2.63e-05	0.000363	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—CYP24A1—multiple sclerosis	2.63e-05	0.000363	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—SRM—multiple sclerosis	2.63e-05	0.000362	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—CYP27B1—multiple sclerosis	2.62e-05	0.000362	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—CYP24A1—multiple sclerosis	2.62e-05	0.000362	CbGpPWpGaD
Ondansetron—OPRM1—GPCR ligand binding—POMC—multiple sclerosis	2.62e-05	0.000361	CbGpPWpGaD
Ondansetron—HTR1A—GPCR downstream signaling—CXCR3—multiple sclerosis	2.61e-05	0.00036	CbGpPWpGaD
Ondansetron—OPRM1—GPCR ligand binding—CCL2—multiple sclerosis	2.56e-05	0.000353	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—CCL3—multiple sclerosis	2.55e-05	0.000351	CbGpPWpGaD
Ondansetron—HTR1A—GPCR downstream signaling—CCR2—multiple sclerosis	2.54e-05	0.00035	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—CXCL10—multiple sclerosis	2.51e-05	0.000347	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—APOE—multiple sclerosis	2.51e-05	0.000346	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—CNR1—multiple sclerosis	2.46e-05	0.00034	CbGpPWpGaD
Ondansetron—CYP2D6—Biological oxidations—POMC—multiple sclerosis	2.45e-05	0.000339	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—PTGER4—multiple sclerosis	2.45e-05	0.000338	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—CXCL13—multiple sclerosis	2.45e-05	0.000337	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—CCR1—multiple sclerosis	2.45e-05	0.000337	CbGpPWpGaD
Ondansetron—OPRM1—GPCR downstream signaling—CXCL10—multiple sclerosis	2.44e-05	0.000337	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—RGS1—multiple sclerosis	2.44e-05	0.000336	CbGpPWpGaD
Ondansetron—CYP2C9—Biological oxidations—POMC—multiple sclerosis	2.43e-05	0.000336	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—GPC5—multiple sclerosis	2.41e-05	0.000332	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—GPC5—multiple sclerosis	2.4e-05	0.000331	CbGpPWpGaD
Ondansetron—HTR1B—GPCR downstream signaling—CCL5—multiple sclerosis	2.38e-05	0.000329	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—CXCR3—multiple sclerosis	2.37e-05	0.000327	CbGpPWpGaD
Ondansetron—HTR1A—GPCR downstream signaling—CNR1—multiple sclerosis	2.34e-05	0.000323	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—GPR65—multiple sclerosis	2.31e-05	0.000318	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—CCR2—multiple sclerosis	2.3e-05	0.000318	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—CD80—multiple sclerosis	2.27e-05	0.000313	CbGpPWpGaD
Ondansetron—HTR1A—GPCR ligand binding—POMC—multiple sclerosis	2.26e-05	0.000312	CbGpPWpGaD
Ondansetron—HTR1A—SIDS Susceptibility Pathways—IL6—multiple sclerosis	2.25e-05	0.000311	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—SRM—multiple sclerosis	2.24e-05	0.000309	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—CXCL10—multiple sclerosis	2.22e-05	0.000306	CbGpPWpGaD
Ondansetron—HTR1A—GPCR ligand binding—CCL2—multiple sclerosis	2.21e-05	0.000305	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—CCL5—multiple sclerosis	2.16e-05	0.000298	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—POMC—multiple sclerosis	2.15e-05	0.000297	CbGpPWpGaD
Ondansetron—HTR1B—GPCR downstream signaling—CCR5—multiple sclerosis	2.15e-05	0.000296	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—CNR1—multiple sclerosis	2.13e-05	0.000293	CbGpPWpGaD
Ondansetron—HTR1B—GPCR downstream signaling—IL2RA—multiple sclerosis	2.12e-05	0.000292	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—CCR1—multiple sclerosis	2.11e-05	0.000291	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—CXCL13—multiple sclerosis	2.11e-05	0.000291	CbGpPWpGaD
Ondansetron—HTR1A—GPCR downstream signaling—CXCL10—multiple sclerosis	2.11e-05	0.000291	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—CCL2—multiple sclerosis	2.11e-05	0.000291	CbGpPWpGaD
Ondansetron—OPRM1—GPCR downstream signaling—CCL5—multiple sclerosis	2.1e-05	0.00029	CbGpPWpGaD
Ondansetron—CYP1A2—Biological oxidations—POMC—multiple sclerosis	2.08e-05	0.000287	CbGpPWpGaD
Ondansetron—HTR4—Signaling by GPCR—MAPK1—multiple sclerosis	2.06e-05	0.000284	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—RRM1—multiple sclerosis	1.99e-05	0.000275	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—RRM1—multiple sclerosis	1.99e-05	0.000274	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—CCL3—multiple sclerosis	1.98e-05	0.000272	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—CCR5—multiple sclerosis	1.95e-05	0.000269	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—IL2RA—multiple sclerosis	1.92e-05	0.000265	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—CXCL10—multiple sclerosis	1.91e-05	0.000264	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—TYK2—multiple sclerosis	1.91e-05	0.000264	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—CCL5—multiple sclerosis	1.91e-05	0.000263	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—PTGER4—multiple sclerosis	1.9e-05	0.000262	CbGpPWpGaD
Ondansetron—OPRM1—GPCR downstream signaling—CCR5—multiple sclerosis	1.89e-05	0.000261	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—PGR—multiple sclerosis	1.87e-05	0.000258	CbGpPWpGaD
Ondansetron—OPRM1—GPCR downstream signaling—IL2RA—multiple sclerosis	1.87e-05	0.000257	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—CYP24A1—multiple sclerosis	1.87e-05	0.000257	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—CYP27B1—multiple sclerosis	1.87e-05	0.000257	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	1.85e-05	0.000255	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	1.85e-05	0.000255	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—CXCR3—multiple sclerosis	1.84e-05	0.000253	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—CD28—multiple sclerosis	1.82e-05	0.000251	CbGpPWpGaD
Ondansetron—HTR1A—GPCR downstream signaling—CCL5—multiple sclerosis	1.81e-05	0.00025	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.81e-05	0.000249	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—CCR2—multiple sclerosis	1.79e-05	0.000246	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—CCL3—multiple sclerosis	1.74e-05	0.00024	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—SRM—multiple sclerosis	1.73e-05	0.000239	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—CCR5—multiple sclerosis	1.72e-05	0.000237	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—GPC5—multiple sclerosis	1.71e-05	0.000235	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—IL2RA—multiple sclerosis	1.7e-05	0.000234	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—GPC5—multiple sclerosis	1.69e-05	0.000233	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—PTGER4—multiple sclerosis	1.68e-05	0.000231	CbGpPWpGaD
Ondansetron—HTR1B—GPCR downstream signaling—POMC—multiple sclerosis	1.68e-05	0.000231	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—PGR—multiple sclerosis	1.65e-05	0.000228	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—CNR1—multiple sclerosis	1.65e-05	0.000227	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—CCL5—multiple sclerosis	1.65e-05	0.000227	CbGpPWpGaD
Ondansetron—HTR1A—GPCR downstream signaling—CCR5—multiple sclerosis	1.63e-05	0.000225	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—CXCR3—multiple sclerosis	1.62e-05	0.000224	CbGpPWpGaD
Ondansetron—HTR1A—GPCR downstream signaling—IL2RA—multiple sclerosis	1.61e-05	0.000222	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—CD28—multiple sclerosis	1.61e-05	0.000221	CbGpPWpGaD
Ondansetron—CYP3A4—Biological oxidations—POMC—multiple sclerosis	1.61e-05	0.000221	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—IL2—multiple sclerosis	1.59e-05	0.00022	CbGpPWpGaD
Ondansetron—HTR4—Signaling by GPCR—IL6—multiple sclerosis	1.58e-05	0.000218	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—CYP24A1—multiple sclerosis	1.58e-05	0.000218	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—CYP27B1—multiple sclerosis	1.58e-05	0.000218	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—BCHE—multiple sclerosis	1.58e-05	0.000218	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—CCR2—multiple sclerosis	1.58e-05	0.000217	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.55e-05	0.000213	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—POMC—multiple sclerosis	1.52e-05	0.00021	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—MMP9—multiple sclerosis	1.51e-05	0.000208	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—CCL3—multiple sclerosis	1.5e-05	0.000208	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—CCL2—multiple sclerosis	1.49e-05	0.000206	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—CCR5—multiple sclerosis	1.48e-05	0.000205	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—CXCL10—multiple sclerosis	1.48e-05	0.000205	CbGpPWpGaD
Ondansetron—OPRM1—GPCR downstream signaling—POMC—multiple sclerosis	1.48e-05	0.000204	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—IL2RA—multiple sclerosis	1.46e-05	0.000202	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—CNR1—multiple sclerosis	1.46e-05	0.000201	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—PTGER4—multiple sclerosis	1.45e-05	0.0002	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—GPC5—multiple sclerosis	1.45e-05	0.000199	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—PGR—multiple sclerosis	1.43e-05	0.000197	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—RRM1—multiple sclerosis	1.41e-05	0.000195	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—RRM1—multiple sclerosis	1.4e-05	0.000193	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—CXCR3—multiple sclerosis	1.4e-05	0.000193	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—CD28—multiple sclerosis	1.39e-05	0.000191	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—CCR2—multiple sclerosis	1.36e-05	0.000188	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—TYK2—multiple sclerosis	1.35e-05	0.000187	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—POMC—multiple sclerosis	1.34e-05	0.000185	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—STAT3—multiple sclerosis	1.34e-05	0.000185	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—CCL2—multiple sclerosis	1.32e-05	0.000181	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—CXCL10—multiple sclerosis	1.31e-05	0.000181	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—CD86—multiple sclerosis	1.3e-05	0.000179	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—CCL5—multiple sclerosis	1.28e-05	0.000176	CbGpPWpGaD
Ondansetron—HTR1A—GPCR downstream signaling—POMC—multiple sclerosis	1.28e-05	0.000176	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—CNR1—multiple sclerosis	1.26e-05	0.000173	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—MYC—multiple sclerosis	1.24e-05	0.000172	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—TGFB1—multiple sclerosis	1.24e-05	0.000171	CbGpPWpGaD
Ondansetron—HTR1B—GPCR downstream signaling—IL2—multiple sclerosis	1.24e-05	0.000171	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	1.22e-05	0.000168	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	1.22e-05	0.000168	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—MAPK1—multiple sclerosis	1.22e-05	0.000168	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—RRM1—multiple sclerosis	1.2e-05	0.000165	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—TYK2—multiple sclerosis	1.19e-05	0.000165	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—SPP1—multiple sclerosis	1.18e-05	0.000163	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—POMC—multiple sclerosis	1.16e-05	0.00016	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—CCR5—multiple sclerosis	1.15e-05	0.000159	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—CD86—multiple sclerosis	1.15e-05	0.000158	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—BCHE—multiple sclerosis	1.14e-05	0.000158	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—BCHE—multiple sclerosis	1.14e-05	0.000158	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—CCL2—multiple sclerosis	1.14e-05	0.000157	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—IL2RA—multiple sclerosis	1.13e-05	0.000156	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—CXCL10—multiple sclerosis	1.13e-05	0.000156	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—CCL5—multiple sclerosis	1.13e-05	0.000156	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—IL2—multiple sclerosis	1.13e-05	0.000155	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—GPC5—multiple sclerosis	1.12e-05	0.000154	CbGpPWpGaD
Ondansetron—OPRM1—GPCR downstream signaling—IL2—multiple sclerosis	1.09e-05	0.000151	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.09e-05	0.00015	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—APOE—multiple sclerosis	1.05e-05	0.000144	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—SPP1—multiple sclerosis	1.04e-05	0.000144	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—TYK2—multiple sclerosis	1.03e-05	0.000142	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—CCR5—multiple sclerosis	1.02e-05	0.00014	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—IL2RA—multiple sclerosis	1e-05	0.000138	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—IL2—multiple sclerosis	9.94e-06	0.000137	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—CD86—multiple sclerosis	9.89e-06	0.000136	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—CCL5—multiple sclerosis	9.73e-06	0.000134	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—APOE—multiple sclerosis	9.51e-06	0.000131	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—CD80—multiple sclerosis	9.47e-06	0.000131	CbGpPWpGaD
Ondansetron—HTR1A—GPCR downstream signaling—IL2—multiple sclerosis	9.45e-06	0.00013	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—IL6—multiple sclerosis	9.36e-06	0.000129	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	9.35e-06	0.000129	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	9.3e-06	0.000128	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—RRM1—multiple sclerosis	9.25e-06	0.000128	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—APOE—multiple sclerosis	9.24e-06	0.000127	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—SPP1—multiple sclerosis	9.02e-06	0.000124	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—POMC—multiple sclerosis	9e-06	0.000124	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—CCL2—multiple sclerosis	8.8e-06	0.000121	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—CCR5—multiple sclerosis	8.77e-06	0.000121	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—IL2RA—multiple sclerosis	8.64e-06	0.000119	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—MAPK1—multiple sclerosis	8.61e-06	0.000119	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—IL2—multiple sclerosis	8.58e-06	0.000118	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	8.52e-06	0.000117	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—CD80—multiple sclerosis	8.36e-06	0.000115	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—POMC—multiple sclerosis	8.17e-06	0.000113	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—BCHE—multiple sclerosis	8.12e-06	0.000112	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—BCHE—multiple sclerosis	8.05e-06	0.000111	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—TYK2—multiple sclerosis	7.99e-06	0.00011	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	7.99e-06	0.00011	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—APOE—multiple sclerosis	7.98e-06	0.00011	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—POMC—multiple sclerosis	7.94e-06	0.00011	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—CCL2—multiple sclerosis	7.77e-06	0.000107	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—MAPK1—multiple sclerosis	7.6e-06	0.000105	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—ALB—multiple sclerosis	7.45e-06	0.000103	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	7.28e-06	0.0001	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—CD80—multiple sclerosis	7.21e-06	9.95e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—TYK2—multiple sclerosis	7.06e-06	9.73e-05	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—APOE—multiple sclerosis	6.89e-06	9.5e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—BCHE—multiple sclerosis	6.88e-06	9.49e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—APOE—multiple sclerosis	6.87e-06	9.48e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—POMC—multiple sclerosis	6.85e-06	9.45e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—CCL2—multiple sclerosis	6.71e-06	9.25e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—IL2—multiple sclerosis	6.65e-06	9.17e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—IL6—multiple sclerosis	6.62e-06	9.13e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—MAPK1—multiple sclerosis	6.56e-06	9.05e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—MMP9—multiple sclerosis	6.3e-06	8.68e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—TYK2—multiple sclerosis	6.09e-06	8.4e-05	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—POMC—multiple sclerosis	5.92e-06	8.16e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—POMC—multiple sclerosis	5.9e-06	8.14e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—IL2—multiple sclerosis	5.87e-06	8.1e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—IL6—multiple sclerosis	5.84e-06	8.06e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—STAT3—multiple sclerosis	5.6e-06	7.72e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—MMP9—multiple sclerosis	5.56e-06	7.66e-05	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—ALB—multiple sclerosis	5.39e-06	7.44e-05	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—ALB—multiple sclerosis	5.38e-06	7.42e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—BCHE—multiple sclerosis	5.31e-06	7.32e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—MYC—multiple sclerosis	5.2e-06	7.17e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—TGFB1—multiple sclerosis	5.19e-06	7.16e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—MAPK1—multiple sclerosis	5.09e-06	7.02e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—IL2—multiple sclerosis	5.07e-06	6.99e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—IL6—multiple sclerosis	5.04e-06	6.95e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—STAT3—multiple sclerosis	4.94e-06	6.81e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—APOE—multiple sclerosis	4.89e-06	6.74e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—APOE—multiple sclerosis	4.84e-06	6.68e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—MMP9—multiple sclerosis	4.8e-06	6.61e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—MYC—multiple sclerosis	4.59e-06	6.33e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—TGFB1—multiple sclerosis	4.58e-06	6.31e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—MAPK1—multiple sclerosis	4.49e-06	6.19e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—STAT3—multiple sclerosis	4.26e-06	5.88e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—POMC—multiple sclerosis	4.2e-06	5.79e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—POMC—multiple sclerosis	4.16e-06	5.74e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—APOE—multiple sclerosis	4.14e-06	5.71e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—MYC—multiple sclerosis	3.96e-06	5.46e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—TGFB1—multiple sclerosis	3.95e-06	5.45e-05	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—IL6—multiple sclerosis	3.91e-06	5.39e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—MAPK1—multiple sclerosis	3.88e-06	5.35e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—ALB—multiple sclerosis	3.83e-06	5.28e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—ALB—multiple sclerosis	3.79e-06	5.23e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—POMC—multiple sclerosis	3.56e-06	4.9e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—IL6—multiple sclerosis	3.45e-06	4.76e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—ALB—multiple sclerosis	3.24e-06	4.47e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—APOE—multiple sclerosis	3.2e-06	4.41e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—IL6—multiple sclerosis	2.98e-06	4.11e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—POMC—multiple sclerosis	2.74e-06	3.79e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—ALB—multiple sclerosis	2.5e-06	3.45e-05	CbGpPWpGaD
